#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Folic acid ( FA ) is a known water-soluble B-vitamin comprising three sub-components : A pterin ring , p-aminobenzoyl residue , and L-glutamic acid (
2-1	16-21	Folic	person|substance[3]	new|new[3]	coref	2-7[5_3]
2-2	22-26	acid	substance[3]	new[3]	_	_
2-3	27-28	(	_	_	_	_
2-4	29-31	FA	abstract	new	coref	6-1
2-5	32-33	)	_	_	_	_
2-6	34-36	is	_	_	_	_
2-7	37-38	a	substance[5]	giv[5]	coref	2-23[12_5]
2-8	39-44	known	substance[5]	giv[5]	_	_
2-9	45-58	water-soluble	substance[5]	giv[5]	_	_
2-10	59-68	B-vitamin	substance[5]	giv[5]	_	_
2-11	69-79	comprising	substance[5]	giv[5]	_	_
2-12	80-85	three	substance[5]|substance[6]	giv[5]|new[6]	appos	2-15[8_6]
2-13	86-100	sub-components	substance[5]|substance[6]	giv[5]|new[6]	_	_
2-14	101-102	:	_	_	_	_
2-15	103-104	A	substance[8]	giv[8]	appos	2-19[10_8]
2-16	105-111	pterin	substance|substance[8]	new|giv[8]	_	_
2-17	112-116	ring	substance[8]	giv[8]	_	_
2-18	117-118	,	_	_	_	_
2-19	119-133	p-aminobenzoyl	substance|substance[10]	new|giv[10]	_	_
2-20	134-141	residue	substance[10]	giv[10]	_	_
2-21	142-143	,	_	_	_	_
2-22	144-147	and	_	_	_	_
2-23	148-158	L-glutamic	substance|substance[12]	new|giv[12]	_	_
2-24	159-163	acid	substance[12]	giv[12]	_	_
2-25	164-165	(	_	_	_	_

#Text=Figure 1
3-1	166-172	Figure	abstract[13]	new[13]	ana	5-1[0_13]
3-2	173-174	1	abstract[13]	new[13]	_	_

#Text=) .
4-1	175-176	)	_	_	_	_
4-2	177-178	.	_	_	_	_

#Text=It is linked with different diseases ;
5-1	179-181	It	abstract	giv	_	_
5-2	182-184	is	_	_	_	_
5-3	185-191	linked	_	_	_	_
5-4	192-196	with	_	_	_	_
5-5	197-206	different	abstract[15]	new[15]	coref	6-26[25_15]
5-6	207-215	diseases	abstract[15]	new[15]	_	_
5-7	216-217	;	_	_	_	_

#Text=FA prevents birth defects of the brain and spinal cord , especially spina bifida , and decreases serum homocysteine levels , reducing the risk of heart diseases .
6-1	218-220	FA	abstract	giv	coref	7-1
6-2	221-229	prevents	_	_	_	_
6-3	230-235	birth	event|abstract[18]	new|new[18]	_	_
6-4	236-243	defects	abstract[18]	new[18]	_	_
6-5	244-246	of	abstract[18]	new[18]	_	_
6-6	247-250	the	abstract[18]|object[19]	new[18]|new[19]	_	_
6-7	251-256	brain	abstract[18]|object[19]	new[18]|new[19]	_	_
6-8	257-260	and	abstract[18]	new[18]	_	_
6-9	261-267	spinal	abstract[18]|object[20]	new[18]|new[20]	_	_
6-10	268-272	cord	abstract[18]|object[20]	new[18]|new[20]	_	_
6-11	273-274	,	_	_	_	_
6-12	275-285	especially	_	_	_	_
6-13	286-291	spina	_	_	_	_
6-14	292-298	bifida	_	_	_	_
6-15	299-300	,	_	_	_	_
6-16	301-304	and	_	_	_	_
6-17	305-314	decreases	_	_	_	_
6-18	315-320	serum	substance|abstract[23]	new|new[23]	coref	22-16
6-19	321-333	homocysteine	abstract|abstract[23]	new|new[23]	_	_
6-20	334-340	levels	abstract[23]	new[23]	_	_
6-21	341-342	,	_	_	_	_
6-22	343-351	reducing	_	_	_	_
6-23	352-355	the	abstract[24]	new[24]	_	_
6-24	356-360	risk	abstract[24]	new[24]	_	_
6-25	361-363	of	abstract[24]	new[24]	_	_
6-26	364-369	heart	abstract[24]|abstract[25]	new[24]|giv[25]	_	_
6-27	370-378	diseases	abstract[24]|abstract[25]	new[24]|giv[25]	_	_
6-28	379-380	.	_	_	_	_

#Text=FA is an essential vitamin that is nowadays prescribed to pregnant women and is indicated in the prevention of certain types of anemia .
7-1	381-383	FA	abstract	giv	coref	7-3[27_0]
7-2	384-386	is	_	_	_	_
7-3	387-389	an	abstract[27]	giv[27]	coref	8-1[0_27]
7-4	390-399	essential	abstract[27]	giv[27]	_	_
7-5	400-407	vitamin	abstract[27]	giv[27]	_	_
7-6	408-412	that	abstract[27]	giv[27]	_	_
7-7	413-415	is	abstract[27]	giv[27]	_	_
7-8	416-424	nowadays	abstract[27]	giv[27]	_	_
7-9	425-435	prescribed	abstract[27]	giv[27]	_	_
7-10	436-438	to	abstract[27]	giv[27]	_	_
7-11	439-447	pregnant	abstract[27]|person[28]	giv[27]|new[28]	_	_
7-12	448-453	women	abstract[27]|person[28]	giv[27]|new[28]	_	_
7-13	454-457	and	abstract[27]	giv[27]	_	_
7-14	458-460	is	abstract[27]	giv[27]	_	_
7-15	461-470	indicated	abstract[27]	giv[27]	_	_
7-16	471-473	in	_	_	_	_
7-17	474-477	the	abstract[29]	new[29]	_	_
7-18	478-488	prevention	abstract[29]	new[29]	_	_
7-19	489-491	of	abstract[29]	new[29]	_	_
7-20	492-499	certain	abstract[29]|abstract[30]	new[29]|new[30]	_	_
7-21	500-505	types	abstract[29]|abstract[30]	new[29]|new[30]	_	_
7-22	506-508	of	abstract[29]|abstract[30]	new[29]|new[30]	_	_
7-23	509-515	anemia	abstract[29]|abstract[30]|abstract	new[29]|new[30]|new	_	_
7-24	516-517	.	_	_	_	_

#Text=FA is also used in bioimaging as an element of orientation toward cancer cells , as folate receptors are highly over-expressed on the surface of many tumors .
8-1	518-520	FA	abstract	giv	coref	9-1
8-2	521-523	is	_	_	_	_
8-3	524-528	also	_	_	_	_
8-4	529-533	used	_	_	_	_
8-5	534-536	in	_	_	_	_
8-6	537-547	bioimaging	abstract	new	_	_
8-7	548-550	as	_	_	_	_
8-8	551-553	an	abstract[34]	new[34]	_	_
8-9	554-561	element	abstract[34]	new[34]	_	_
8-10	562-564	of	abstract[34]	new[34]	_	_
8-11	565-576	orientation	abstract[34]|abstract[35]	new[34]|new[35]	_	_
8-12	577-583	toward	abstract[34]|abstract[35]	new[34]|new[35]	_	_
8-13	584-590	cancer	abstract[34]|abstract[35]|abstract|animal[37]	new[34]|new[35]|new|new[37]	coref	20-22[129_37]
8-14	591-596	cells	abstract[34]|abstract[35]|animal[37]	new[34]|new[35]|new[37]	_	_
8-15	597-598	,	_	_	_	_
8-16	599-601	as	_	_	_	_
8-17	602-608	folate	substance|abstract[39]	new|new[39]	_	_
8-18	609-618	receptors	abstract[39]	new[39]	_	_
8-19	619-622	are	_	_	_	_
8-20	623-629	highly	_	_	_	_
8-21	630-644	over-expressed	_	_	_	_
8-22	645-647	on	_	_	_	_
8-23	648-651	the	place[40]	new[40]	_	_
8-24	652-659	surface	place[40]	new[40]	_	_
8-25	660-662	of	place[40]	new[40]	_	_
8-26	663-667	many	place[40]|animal[41]	new[40]|new[41]	_	_
8-27	668-674	tumors	place[40]|animal[41]	new[40]|new[41]	_	_
8-28	675-676	.	_	_	_	_

#Text=FA plays an important role in the proper development of physiological processes in the body .
9-1	677-679	FA	abstract	giv	coref	10-9
9-2	680-685	plays	_	_	_	_
9-3	686-688	an	abstract[43]	new[43]	_	_
9-4	689-698	important	abstract[43]	new[43]	_	_
9-5	699-703	role	abstract[43]	new[43]	_	_
9-6	704-706	in	abstract[43]	new[43]	_	_
9-7	707-710	the	abstract[43]|event[44]	new[43]|new[44]	_	_
9-8	711-717	proper	abstract[43]|event[44]	new[43]|new[44]	_	_
9-9	718-729	development	abstract[43]|event[44]	new[43]|new[44]	_	_
9-10	730-732	of	abstract[43]|event[44]	new[43]|new[44]	_	_
9-11	733-746	physiological	abstract[43]|event[44]|abstract[45]	new[43]|new[44]|new[45]	_	_
9-12	747-756	processes	abstract[43]|event[44]|abstract[45]	new[43]|new[44]|new[45]	_	_
9-13	757-759	in	abstract[43]|event[44]|abstract[45]	new[43]|new[44]|new[45]	_	_
9-14	760-763	the	abstract[43]|event[44]|abstract[45]|object[46]	new[43]|new[44]|new[45]|new[46]	coref	10-1[47_46]
9-15	764-768	body	abstract[43]|event[44]|abstract[45]|object[46]	new[43]|new[44]|new[45]|new[46]	_	_
9-16	769-770	.	_	_	_	_

#Text=The human body is not able to synthesize FA , and its presence in foods such as spinach , cereals , citrus , rice , and beans may not be enough to meet the daily requirement for this vitamin .
10-1	771-774	The	object[47]	giv[47]	_	_
10-2	775-780	human	object[47]	giv[47]	_	_
10-3	781-785	body	object[47]	giv[47]	_	_
10-4	786-788	is	_	_	_	_
10-5	789-792	not	_	_	_	_
10-6	793-797	able	_	_	_	_
10-7	798-800	to	_	_	_	_
10-8	801-811	synthesize	_	_	_	_
10-9	812-814	FA	abstract	giv	ana	10-12
10-10	815-816	,	_	_	_	_
10-11	817-820	and	_	_	_	_
10-12	821-824	its	abstract|abstract[50]	giv|new[50]	coref	10-38[58_0]
10-13	825-833	presence	abstract[50]	new[50]	_	_
10-14	834-836	in	abstract[50]	new[50]	_	_
10-15	837-842	foods	abstract[50]|substance[51]	new[50]|new[51]	coref	11-5[60_51]
10-16	843-847	such	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-17	848-850	as	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-18	851-858	spinach	abstract[50]|substance[51]|plant	new[50]|new[51]|new	_	_
10-19	859-860	,	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-20	861-868	cereals	abstract[50]|substance[51]|plant	new[50]|new[51]|new	_	_
10-21	869-870	,	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-22	871-877	citrus	abstract[50]|substance[51]|plant	new[50]|new[51]|new	coref	11-12
10-23	878-879	,	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-24	880-884	rice	abstract[50]|substance[51]|substance	new[50]|new[51]|new	_	_
10-25	885-886	,	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-26	887-890	and	abstract[50]|substance[51]	new[50]|new[51]	_	_
10-27	891-896	beans	abstract[50]|substance[51]|plant	new[50]|new[51]|new	_	_
10-28	897-900	may	_	_	_	_
10-29	901-904	not	_	_	_	_
10-30	905-907	be	_	_	_	_
10-31	908-914	enough	_	_	_	_
10-32	915-917	to	_	_	_	_
10-33	918-922	meet	_	_	_	_
10-34	923-926	the	abstract[57]	new[57]	_	_
10-35	927-932	daily	abstract[57]	new[57]	_	_
10-36	933-944	requirement	abstract[57]	new[57]	_	_
10-37	945-948	for	abstract[57]	new[57]	_	_
10-38	949-953	this	abstract[57]|abstract[58]	new[57]|giv[58]	coref	11-8[0_58]
10-39	954-961	vitamin	abstract[57]|abstract[58]	new[57]|giv[58]	_	_
10-40	962-963	.	_	_	_	_

#Text=The daily consumption of foods fortified with FA , such as citrus beverages , can provide the amount required for human health .
11-1	964-967	The	event[59]	new[59]	_	_
11-2	968-973	daily	event[59]	new[59]	_	_
11-3	974-985	consumption	event[59]	new[59]	_	_
11-4	986-988	of	event[59]	new[59]	_	_
11-5	989-994	foods	event[59]|substance[60]	new[59]|giv[60]	_	_
11-6	995-1004	fortified	event[59]|substance[60]	new[59]|giv[60]	_	_
11-7	1005-1009	with	event[59]|substance[60]	new[59]|giv[60]	_	_
11-8	1010-1012	FA	event[59]|substance[60]|abstract	new[59]|giv[60]|giv	coref	12-11[67_0]
11-9	1013-1014	,	event[59]|substance[60]	new[59]|giv[60]	_	_
11-10	1015-1019	such	event[59]|substance[60]	new[59]|giv[60]	_	_
11-11	1020-1022	as	event[59]|substance[60]	new[59]|giv[60]	_	_
11-12	1023-1029	citrus	event[59]|substance[60]|plant|substance[63]	new[59]|giv[60]|giv|new[63]	coref	12-13[68_63]
11-13	1030-1039	beverages	event[59]|substance[60]|substance[63]	new[59]|giv[60]|new[63]	_	_
11-14	1040-1041	,	_	_	_	_
11-15	1042-1045	can	_	_	_	_
11-16	1046-1053	provide	_	_	_	_
11-17	1054-1057	the	abstract[64]	new[64]	_	_
11-18	1058-1064	amount	abstract[64]	new[64]	_	_
11-19	1065-1073	required	abstract[64]	new[64]	_	_
11-20	1074-1077	for	abstract[64]	new[64]	_	_
11-21	1078-1083	human	abstract[64]|abstract[65]	new[64]|new[65]	_	_
11-22	1084-1090	health	abstract[64]|abstract[65]	new[64]|new[65]	_	_
11-23	1091-1092	.	_	_	_	_

#Text=Therefore , having a simple and fast method for determining FA in commercial beverages is of great interest .
12-1	1093-1102	Therefore	_	_	_	_
12-2	1103-1104	,	_	_	_	_
12-3	1105-1111	having	_	_	_	_
12-4	1112-1113	a	abstract[66]	new[66]	coref	16-6[92_66]
12-5	1114-1120	simple	abstract[66]	new[66]	_	_
12-6	1121-1124	and	abstract[66]	new[66]	_	_
12-7	1125-1129	fast	abstract[66]	new[66]	_	_
12-8	1130-1136	method	abstract[66]	new[66]	_	_
12-9	1137-1140	for	abstract[66]	new[66]	_	_
12-10	1141-1152	determining	abstract[66]	new[66]	_	_
12-11	1153-1155	FA	abstract[66]|abstract[67]	new[66]|giv[67]	coref	13-13[0_67]
12-12	1156-1158	in	abstract[66]|abstract[67]	new[66]|giv[67]	_	_
12-13	1159-1169	commercial	abstract[66]|abstract[67]|substance[68]	new[66]|giv[67]|giv[68]	coref	31-31[232_68]
12-14	1170-1179	beverages	abstract[66]|abstract[67]|substance[68]	new[66]|giv[67]|giv[68]	_	_
12-15	1180-1182	is	_	_	_	_
12-16	1183-1185	of	_	_	_	_
12-17	1186-1191	great	abstract[69]	new[69]	_	_
12-18	1192-1200	interest	abstract[69]	new[69]	_	_
12-19	1201-1202	.	_	_	_	_

#Text=Different methods have been reported in the literature for the quantification of FA , including spectrophotometric methods , electrochemical techniques , high-performance liquid chromatography ( HPLC ) and ultrahigh HPLC , and ion chromatography .
13-1	1203-1212	Different	abstract[70]	new[70]	coref	13-16[74_70]
13-2	1213-1220	methods	abstract[70]	new[70]	_	_
13-3	1221-1225	have	_	_	_	_
13-4	1226-1230	been	_	_	_	_
13-5	1231-1239	reported	_	_	_	_
13-6	1240-1242	in	_	_	_	_
13-7	1243-1246	the	abstract[71]	new[71]	_	_
13-8	1247-1257	literature	abstract[71]	new[71]	_	_
13-9	1258-1261	for	_	_	_	_
13-10	1262-1265	the	abstract[72]	new[72]	_	_
13-11	1266-1280	quantification	abstract[72]	new[72]	_	_
13-12	1281-1283	of	abstract[72]	new[72]	_	_
13-13	1284-1286	FA	abstract[72]|abstract	new[72]|giv	coref	16-23
13-14	1287-1288	,	abstract[72]	new[72]	_	_
13-15	1289-1298	including	abstract[72]	new[72]	_	_
13-16	1299-1317	spectrophotometric	abstract[72]|abstract[74]|abstract[75]	new[72]|giv[74]|giv[75]	coref|coref	13-16[75_74]|14-4[83_75]
13-17	1318-1325	methods	abstract[72]|abstract[74]|abstract[75]	new[72]|giv[74]|giv[75]	_	_
13-18	1326-1327	,	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-19	1328-1343	electrochemical	abstract[72]|abstract[75]|abstract[76]	new[72]|giv[75]|new[76]	_	_
13-20	1344-1354	techniques	abstract[72]|abstract[75]|abstract[76]	new[72]|giv[75]|new[76]	_	_
13-21	1355-1356	,	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-22	1357-1373	high-performance	abstract[72]|abstract[75]|object[78]	new[72]|giv[75]|new[78]	_	_
13-23	1374-1380	liquid	abstract[72]|abstract[75]|substance|object[78]	new[72]|giv[75]|new|new[78]	_	_
13-24	1381-1395	chromatography	abstract[72]|abstract[75]|object[78]	new[72]|giv[75]|new[78]	_	_
13-25	1396-1397	(	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-26	1398-1402	HPLC	abstract[72]|abstract[75]|abstract	new[72]|giv[75]|new	coref	13-29[80_0]
13-27	1403-1404	)	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-28	1405-1408	and	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-29	1409-1418	ultrahigh	abstract[72]|abstract[75]|abstract[80]	new[72]|giv[75]|giv[80]	_	_
13-30	1419-1423	HPLC	abstract[72]|abstract[75]|abstract[80]	new[72]|giv[75]|giv[80]	_	_
13-31	1424-1425	,	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-32	1426-1429	and	abstract[72]|abstract[75]	new[72]|giv[75]	_	_
13-33	1430-1433	ion	abstract[72]|abstract[75]|abstract|abstract[82]	new[72]|giv[75]|new|new[82]	_	_
13-34	1434-1448	chromatography	abstract[72]|abstract[75]|abstract[82]	new[72]|giv[75]|new[82]	_	_
13-35	1449-1450	.	_	_	_	_

#Text=In general , these methods are based on time-consuming reactions that involve laborious and slow procedures .
14-1	1451-1453	In	_	_	_	_
14-2	1454-1461	general	_	_	_	_
14-3	1462-1463	,	_	_	_	_
14-4	1464-1469	these	abstract[83]	giv[83]	coref	15-4[86_83]
14-5	1470-1477	methods	abstract[83]	giv[83]	_	_
14-6	1478-1481	are	_	_	_	_
14-7	1482-1487	based	_	_	_	_
14-8	1488-1490	on	_	_	_	_
14-9	1491-1505	time-consuming	event[84]	new[84]	_	_
14-10	1506-1515	reactions	event[84]	new[84]	_	_
14-11	1516-1520	that	event[84]	new[84]	_	_
14-12	1521-1528	involve	event[84]	new[84]	_	_
14-13	1529-1538	laborious	event[84]|event[85]	new[84]|new[85]	_	_
14-14	1539-1542	and	event[84]|event[85]	new[84]|new[85]	_	_
14-15	1543-1547	slow	event[84]|event[85]	new[84]|new[85]	_	_
14-16	1548-1558	procedures	event[84]|event[85]	new[84]|new[85]	_	_
14-17	1559-1560	.	_	_	_	_

#Text=In particular , the chromatographic methods require expensive equipment and the use of large volumes of organic solvents .
15-1	1561-1563	In	_	_	_	_
15-2	1564-1574	particular	_	_	_	_
15-3	1575-1576	,	_	_	_	_
15-4	1577-1580	the	abstract[86]	giv[86]	coref	17-1[101_86]
15-5	1581-1596	chromatographic	abstract[86]	giv[86]	_	_
15-6	1597-1604	methods	abstract[86]	giv[86]	_	_
15-7	1605-1612	require	_	_	_	_
15-8	1613-1622	expensive	object[87]	new[87]	_	_
15-9	1623-1632	equipment	object[87]	new[87]	_	_
15-10	1633-1636	and	_	_	_	_
15-11	1637-1640	the	abstract[88]	new[88]	_	_
15-12	1641-1644	use	abstract[88]	new[88]	_	_
15-13	1645-1647	of	abstract[88]	new[88]	_	_
15-14	1648-1653	large	abstract[88]|abstract[89]	new[88]|new[89]	_	_
15-15	1654-1661	volumes	abstract[88]|abstract[89]	new[88]|new[89]	_	_
15-16	1662-1664	of	abstract[88]|abstract[89]	new[88]|new[89]	_	_
15-17	1665-1672	organic	abstract[88]|abstract[89]|substance[90]	new[88]|new[89]|new[90]	_	_
15-18	1673-1681	solvents	abstract[88]|abstract[89]|substance[90]	new[88]|new[89]|new[90]	_	_
15-19	1682-1683	.	_	_	_	_

#Text=Therefore , the development of a simple , accurate , and low-cost method with high sensitivity and selectivity for the determination of FA is of great importance for monitoring the quality of food products .
16-1	1684-1693	Therefore	_	_	_	_
16-2	1694-1695	,	_	_	_	_
16-3	1696-1699	the	event[91]	new[91]	_	_
16-4	1700-1711	development	event[91]	new[91]	_	_
16-5	1712-1714	of	event[91]	new[91]	_	_
16-6	1715-1716	a	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-7	1717-1723	simple	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-8	1724-1725	,	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-9	1726-1734	accurate	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-10	1735-1736	,	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-11	1737-1740	and	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-12	1741-1749	low-cost	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-13	1750-1756	method	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-14	1757-1761	with	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-15	1762-1766	high	event[91]|abstract[92]|abstract[93]	new[91]|giv[92]|new[93]	coref	17-16[0_93]
16-16	1767-1778	sensitivity	event[91]|abstract[92]|abstract[93]	new[91]|giv[92]|new[93]	_	_
16-17	1779-1782	and	event[91]|abstract[92]	new[91]|giv[92]	_	_
16-18	1783-1794	selectivity	event[91]|abstract[92]|abstract[94]	new[91]|giv[92]|new[94]	coref	17-13[105_94]
16-19	1795-1798	for	event[91]|abstract[92]|abstract[94]	new[91]|giv[92]|new[94]	_	_
16-20	1799-1802	the	event[91]|abstract[92]|abstract[94]|abstract[95]	new[91]|giv[92]|new[94]|new[95]	coref	21-7[132_95]
16-21	1803-1816	determination	event[91]|abstract[92]|abstract[94]|abstract[95]	new[91]|giv[92]|new[94]|new[95]	_	_
16-22	1817-1819	of	event[91]|abstract[92]|abstract[94]|abstract[95]	new[91]|giv[92]|new[94]|new[95]	_	_
16-23	1820-1822	FA	event[91]|abstract[92]|abstract[94]|abstract[95]|abstract	new[91]|giv[92]|new[94]|new[95]|giv	coref	21-10
16-24	1823-1825	is	_	_	_	_
16-25	1826-1828	of	_	_	_	_
16-26	1829-1834	great	abstract[97]	new[97]	_	_
16-27	1835-1845	importance	abstract[97]	new[97]	_	_
16-28	1846-1849	for	abstract[97]	new[97]	_	_
16-29	1850-1860	monitoring	abstract[97]	new[97]	_	_
16-30	1861-1864	the	abstract[97]|abstract[98]	new[97]|new[98]	_	_
16-31	1865-1872	quality	abstract[97]|abstract[98]	new[97]|new[98]	_	_
16-32	1873-1875	of	abstract[97]|abstract[98]	new[97]|new[98]	_	_
16-33	1876-1880	food	abstract[97]|abstract[98]|abstract[99]	new[97]|new[98]|new[99]	_	_
16-34	1881-1889	products	abstract[97]|abstract[98]|abstract[99]	new[97]|new[98]|new[99]	_	_
16-35	1890-1891	.	_	_	_	_

#Text=Fluorescence methods have gained considerable attention in recent years , due to their selectivity , sensitivity , easy sample preparation , and rapid analysis .
17-1	1892-1904	Fluorescence	abstract|abstract[101]	new|giv[101]	ana|coref	17-13[0_101]|22-23
17-2	1905-1912	methods	abstract[101]	giv[101]	_	_
17-3	1913-1917	have	_	_	_	_
17-4	1918-1924	gained	_	_	_	_
17-5	1925-1937	considerable	abstract[102]	new[102]	_	_
17-6	1938-1947	attention	abstract[102]	new[102]	_	_
17-7	1948-1950	in	_	_	_	_
17-8	1951-1957	recent	time[103]	new[103]	ana	18-18[0_103]
17-9	1958-1963	years	time[103]	new[103]	_	_
17-10	1964-1965	,	_	_	_	_
17-11	1966-1969	due	_	_	_	_
17-12	1970-1972	to	_	_	_	_
17-13	1973-1978	their	abstract|abstract[105]	giv|giv[105]	coref	21-5[131_0]
17-14	1979-1990	selectivity	abstract[105]	giv[105]	_	_
17-15	1991-1992	,	_	_	_	_
17-16	1993-2004	sensitivity	abstract	giv	_	_
17-17	2005-2006	,	_	_	_	_
17-18	2007-2011	easy	event[107]	new[107]	_	_
17-19	2012-2018	sample	event[107]	new[107]	_	_
17-20	2019-2030	preparation	event[107]	new[107]	_	_
17-21	2031-2032	,	_	_	_	_
17-22	2033-2036	and	_	_	_	_
17-23	2037-2042	rapid	abstract[108]	new[108]	_	_
17-24	2043-2051	analysis	abstract[108]	new[108]	_	_
17-25	2052-2053	.	_	_	_	_

#Text=As a kind of new fluorophore , quantum dots ( QDs ) are a favorable alternative as they have advantages over conventional organic fluorescent dyes .
18-1	2054-2056	As	_	_	_	_
18-2	2057-2058	a	_	_	_	_
18-3	2059-2063	kind	substance[109]	new[109]	_	_
18-4	2064-2066	of	substance[109]	new[109]	_	_
18-5	2067-2070	new	substance[109]	new[109]	_	_
18-6	2071-2082	fluorophore	substance[109]	new[109]	_	_
18-7	2083-2084	,	_	_	_	_
18-8	2085-2092	quantum	abstract[110]	new[110]	coref	18-14[112_110]
18-9	2093-2097	dots	abstract[110]	new[110]	_	_
18-10	2098-2099	(	_	_	_	_
18-11	2100-2103	QDs	person	new	coref	20-1
18-12	2104-2105	)	_	_	_	_
18-13	2106-2109	are	_	_	_	_
18-14	2110-2111	a	abstract[112]	giv[112]	_	_
18-15	2112-2121	favorable	abstract[112]	giv[112]	_	_
18-16	2122-2133	alternative	abstract[112]	giv[112]	_	_
18-17	2134-2136	as	_	_	_	_
18-18	2137-2141	they	time	giv	ana	19-1
18-19	2142-2146	have	_	_	_	_
18-20	2147-2157	advantages	abstract[114]	new[114]	_	_
18-21	2158-2162	over	abstract[114]	new[114]	_	_
18-22	2163-2175	conventional	abstract[114]|substance[115]	new[114]|new[115]	_	_
18-23	2176-2183	organic	abstract[114]|substance[115]	new[114]|new[115]	_	_
18-24	2184-2195	fluorescent	abstract[114]|substance[115]	new[114]|new[115]	_	_
18-25	2196-2200	dyes	abstract[114]|substance[115]	new[114]|new[115]	_	_
18-26	2201-2202	.	_	_	_	_

#Text=They have unusual optical and electronic properties as a consequence of the quantum confinement effect .
19-1	2203-2207	They	time	giv	coref	21-2[130_0]
19-2	2208-2212	have	_	_	_	_
19-3	2213-2220	unusual	abstract[117]	new[117]	_	_
19-4	2221-2228	optical	abstract[117]	new[117]	_	_
19-5	2229-2232	and	abstract[117]	new[117]	_	_
19-6	2233-2243	electronic	abstract[117]	new[117]	_	_
19-7	2244-2254	properties	abstract[117]	new[117]	_	_
19-8	2255-2257	as	_	_	_	_
19-9	2258-2259	a	abstract[118]	new[118]	_	_
19-10	2260-2271	consequence	abstract[118]	new[118]	_	_
19-11	2272-2274	of	abstract[118]	new[118]	_	_
19-12	2275-2278	the	abstract[118]|abstract[120]	new[118]|new[120]	_	_
19-13	2279-2286	quantum	abstract[118]|abstract[119]|abstract[120]	new[118]|new[119]|new[120]	_	_
19-14	2287-2298	confinement	abstract[118]|abstract[119]|abstract[120]	new[118]|new[119]|new[120]	_	_
19-15	2299-2305	effect	abstract[118]|abstract[120]	new[118]|new[120]	_	_
19-16	2306-2307	.	_	_	_	_

#Text=QDs have been proven to be effective in different applications as biological biomarkers , sensors , drug delivery systems , and solar cells .
20-1	2308-2311	QDs	person	giv	coref	23-9[161_0]
20-2	2312-2316	have	_	_	_	_
20-3	2317-2321	been	_	_	_	_
20-4	2322-2328	proven	_	_	_	_
20-5	2329-2331	to	_	_	_	_
20-6	2332-2334	be	_	_	_	_
20-7	2335-2344	effective	_	_	_	_
20-8	2345-2347	in	_	_	_	_
20-9	2348-2357	different	abstract[122]	new[122]	_	_
20-10	2358-2370	applications	abstract[122]	new[122]	_	_
20-11	2371-2373	as	abstract[122]	new[122]	_	_
20-12	2374-2384	biological	abstract[122]|abstract[123]	new[122]|new[123]	_	_
20-13	2385-2395	biomarkers	abstract[122]|abstract[123]	new[122]|new[123]	_	_
20-14	2396-2397	,	abstract[122]	new[122]	_	_
20-15	2398-2405	sensors	abstract[122]|object	new[122]|new	_	_
20-16	2406-2407	,	abstract[122]	new[122]	_	_
20-17	2408-2412	drug	abstract[122]|substance|abstract[126]|abstract[127]	new[122]|new|new[126]|new[127]	_	_
20-18	2413-2421	delivery	abstract[122]|abstract[126]|abstract[127]	new[122]|new[126]|new[127]	_	_
20-19	2422-2429	systems	abstract[122]|abstract[127]	new[122]|new[127]	_	_
20-20	2430-2431	,	abstract[122]	new[122]	_	_
20-21	2432-2435	and	abstract[122]	new[122]	_	_
20-22	2436-2441	solar	abstract[122]|person|animal[129]	new[122]|new|giv[129]	_	_
20-23	2442-2447	cells	abstract[122]|animal[129]	new[122]|giv[129]	_	_
20-24	2448-2449	.	_	_	_	_

#Text=In recent years , methods for the determination of FA based on the use of nanomaterials have been reported .
21-1	2450-2452	In	_	_	_	_
21-2	2453-2459	recent	time[130]	giv[130]	_	_
21-3	2460-2465	years	time[130]	giv[130]	_	_
21-4	2466-2467	,	_	_	_	_
21-5	2468-2475	methods	abstract[131]	giv[131]	_	_
21-6	2476-2479	for	abstract[131]	giv[131]	_	_
21-7	2480-2483	the	abstract[131]|abstract[132]	giv[131]|giv[132]	coref	22-40[156_132]
21-8	2484-2497	determination	abstract[131]|abstract[132]	giv[131]|giv[132]	_	_
21-9	2498-2500	of	abstract[131]|abstract[132]	giv[131]|giv[132]	_	_
21-10	2501-2503	FA	abstract[131]|abstract[132]|abstract	giv[131]|giv[132]|giv	coref	22-43
21-11	2504-2509	based	abstract[131]	giv[131]	_	_
21-12	2510-2512	on	abstract[131]	giv[131]	_	_
21-13	2513-2516	the	abstract[131]|abstract[134]	giv[131]|new[134]	_	_
21-14	2517-2520	use	abstract[131]|abstract[134]	giv[131]|new[134]	_	_
21-15	2521-2523	of	abstract[131]|abstract[134]	giv[131]|new[134]	_	_
21-16	2524-2537	nanomaterials	abstract[131]|abstract[134]|object	giv[131]|new[134]|new	_	_
21-17	2538-2542	have	_	_	_	_
21-18	2543-2547	been	_	_	_	_
21-19	2548-2556	reported	_	_	_	_
21-20	2557-2558	.	_	_	_	_

#Text=Graphene oxide/Ag nanoparticle hybrids with surface-enhanced Raman spectroscopy ( SERS ) detection , a bovine serum albumin ( BSA)-modified gold nanocluster with fluorescence detection , and a ZrO2 nanoparticle-modified carbon paste electrode with voltammetry detection have been used in the determination of FA .
22-1	2559-2567	Graphene	abstract[137]|abstract[138]	new[137]|new[138]	_	_
22-2	2568-2576	oxide/Ag	substance|abstract[137]|abstract[138]	new|new[137]|new[138]	_	_
22-3	2577-2589	nanoparticle	abstract[137]|abstract[138]	new[137]|new[138]	_	_
22-4	2590-2597	hybrids	abstract[138]	new[138]	_	_
22-5	2598-2602	with	abstract[138]	new[138]	_	_
22-6	2603-2619	surface-enhanced	abstract[138]|abstract[142]	new[138]|new[142]	coref	22-23[149_142]
22-7	2620-2625	Raman	abstract[138]|person|abstract[140]|abstract[142]	new[138]|new|new[140]|new[142]	appos	22-10[0_140]
22-8	2626-2638	spectroscopy	abstract[138]|abstract[140]|abstract[142]	new[138]|new[140]|new[142]	_	_
22-9	2639-2640	(	abstract[138]|abstract[142]	new[138]|new[142]	_	_
22-10	2641-2645	SERS	abstract[138]|abstract|abstract[142]	new[138]|giv|new[142]	coref	34-12[248_0]
22-11	2646-2647	)	abstract[138]|abstract[142]	new[138]|new[142]	_	_
22-12	2648-2657	detection	abstract[138]|abstract[142]	new[138]|new[142]	_	_
22-13	2658-2659	,	_	_	_	_
22-14	2660-2661	a	object[147]	new[147]	_	_
22-15	2662-2668	bovine	place|substance[145]|object[147]	new|new[145]|new[147]	_	_
22-16	2669-2674	serum	substance|substance[145]|object[147]	giv|new[145]|new[147]	_	_
22-17	2675-2682	albumin	substance[145]|object[147]	new[145]|new[147]	_	_
22-18	2683-2684	(	object[147]	new[147]	_	_
22-19	2685-2698	BSA)-modified	object[147]	new[147]	_	_
22-20	2699-2703	gold	substance|object[147]	new|new[147]	_	_
22-21	2704-2715	nanocluster	object[147]	new[147]	_	_
22-22	2716-2720	with	object[147]	new[147]	_	_
22-23	2721-2733	fluorescence	object[147]|abstract|abstract[149]	new[147]|giv|giv[149]	coref|coref	22-34[155_149]|34-22
22-24	2734-2743	detection	object[147]|abstract[149]	new[147]|giv[149]	_	_
22-25	2744-2745	,	_	_	_	_
22-26	2746-2749	and	_	_	_	_
22-27	2750-2751	a	object[153]	new[153]	_	_
22-28	2752-2756	ZrO2	abstract|object[153]	new|new[153]	_	_
22-29	2757-2778	nanoparticle-modified	object[153]	new[153]	_	_
22-30	2779-2785	carbon	substance|object[153]	new|new[153]	_	_
22-31	2786-2791	paste	substance|object[153]	new|new[153]	_	_
22-32	2792-2801	electrode	object[153]	new[153]	_	_
22-33	2802-2806	with	object[153]	new[153]	_	_
22-34	2807-2818	voltammetry	object[153]|abstract|abstract[155]	new[153]|new|giv[155]	coref	40-14[0_155]
22-35	2819-2828	detection	object[153]|abstract[155]	new[153]|giv[155]	_	_
22-36	2829-2833	have	_	_	_	_
22-37	2834-2838	been	_	_	_	_
22-38	2839-2843	used	_	_	_	_
22-39	2844-2846	in	_	_	_	_
22-40	2847-2850	the	abstract[156]	giv[156]	coref	30-16[218_156]
22-41	2851-2864	determination	abstract[156]	giv[156]	_	_
22-42	2865-2867	of	abstract[156]	giv[156]	_	_
22-43	2868-2870	FA	abstract[156]|abstract	giv[156]|giv	coref	23-7
22-44	2871-2872	.	_	_	_	_

#Text=Other works show the determination of FA using QDs capped with thiolated ligands as thioglycolic ( TGA ) and mercaptopropionic ( MPA ) acids .
23-1	2873-2878	Other	abstract[158]	new[158]	coref	29-3[208_158]
23-2	2879-2884	works	abstract[158]	new[158]	_	_
23-3	2885-2889	show	_	_	_	_
23-4	2890-2893	the	abstract[159]	new[159]	_	_
23-5	2894-2907	determination	abstract[159]	new[159]	_	_
23-6	2908-2910	of	abstract[159]	new[159]	_	_
23-7	2911-2913	FA	abstract[159]|abstract	new[159]|giv	coref	25-5
23-8	2914-2919	using	abstract[159]	new[159]	_	_
23-9	2920-2923	QDs	abstract[159]|person[161]	new[159]|giv[161]	coref	24-25[173_161]
23-10	2924-2930	capped	abstract[159]|person[161]	new[159]|giv[161]	_	_
23-11	2931-2935	with	abstract[159]|person[161]	new[159]|giv[161]	_	_
23-12	2936-2945	thiolated	abstract[159]|person[161]|substance[162]	new[159]|giv[161]|new[162]	_	_
23-13	2946-2953	ligands	abstract[159]|person[161]|substance[162]	new[159]|giv[161]|new[162]	_	_
23-14	2954-2956	as	abstract[159]|person[161]|substance[162]	new[159]|giv[161]|new[162]	_	_
23-15	2957-2969	thioglycolic	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-16	2970-2971	(	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-17	2972-2975	TGA	abstract[159]|person[161]|substance[162]|substance|substance[166]	new[159]|giv[161]|new[162]|new|new[166]	_	_
23-18	2976-2977	)	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-19	2978-2981	and	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-20	2982-2999	mercaptopropionic	abstract[159]|person[161]|substance[162]|abstract|substance[166]	new[159]|giv[161]|new[162]|new|new[166]	appos	23-22
23-21	3000-3001	(	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-22	3002-3005	MPA	abstract[159]|person[161]|substance[162]|abstract|substance[166]	new[159]|giv[161]|new[162]|giv|new[166]	_	_
23-23	3006-3007	)	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-24	3008-3013	acids	abstract[159]|person[161]|substance[162]|substance[166]	new[159]|giv[161]|new[162]|new[166]	_	_
23-25	3014-3015	.	_	_	_	_

#Text=However , in these nanoparticles , at pH 8 , the carboxylate groups are dissociated , giving a negative charge to the surface of the QDs .
24-1	3016-3023	However	_	_	_	_
24-2	3024-3025	,	_	_	_	_
24-3	3026-3028	in	_	_	_	_
24-4	3029-3034	these	object[167]	new[167]	_	_
24-5	3035-3048	nanoparticles	object[167]	new[167]	_	_
24-6	3049-3050	,	_	_	_	_
24-7	3051-3053	at	_	_	_	_
24-8	3054-3056	pH	abstract[168]	new[168]	coref	26-12[184_168]
24-9	3057-3058	8	abstract[168]	new[168]	_	_
24-10	3059-3060	,	_	_	_	_
24-11	3061-3064	the	person[170]	new[170]	coref	26-6[183_170]
24-12	3065-3076	carboxylate	object|person[170]	new|new[170]	_	_
24-13	3077-3083	groups	person[170]	new[170]	_	_
24-14	3084-3087	are	_	_	_	_
24-15	3088-3099	dissociated	_	_	_	_
24-16	3100-3101	,	_	_	_	_
24-17	3102-3108	giving	_	_	_	_
24-18	3109-3110	a	abstract[171]	new[171]	_	_
24-19	3111-3119	negative	abstract[171]	new[171]	_	_
24-20	3120-3126	charge	abstract[171]	new[171]	_	_
24-21	3127-3129	to	_	_	_	_
24-22	3130-3133	the	place[172]	new[172]	_	_
24-23	3134-3141	surface	place[172]	new[172]	_	_
24-24	3142-3144	of	place[172]	new[172]	_	_
24-25	3145-3148	the	place[172]|person[173]	new[172]|giv[173]	coref	25-15[177_173]
24-26	3149-3152	QDs	place[172]|person[173]	new[172]|giv[173]	_	_
24-27	3153-3154	.	_	_	_	_

#Text=Under these conditions , FA is also negatively charged , and the interaction between the QDs and FA is not favored , due to electrostatic repulsions .
25-1	3155-3160	Under	_	_	_	_
25-2	3161-3166	these	abstract[174]	new[174]	_	_
25-3	3167-3177	conditions	abstract[174]	new[174]	_	_
25-4	3178-3179	,	_	_	_	_
25-5	3180-3182	FA	abstract	giv	coref	25-18
25-6	3183-3185	is	_	_	_	_
25-7	3186-3190	also	_	_	_	_
25-8	3191-3201	negatively	_	_	_	_
25-9	3202-3209	charged	_	_	_	_
25-10	3210-3211	,	_	_	_	_
25-11	3212-3215	and	_	_	_	_
25-12	3216-3219	the	abstract[176]	new[176]	_	_
25-13	3220-3231	interaction	abstract[176]	new[176]	_	_
25-14	3232-3239	between	abstract[176]	new[176]	_	_
25-15	3240-3243	the	abstract[176]|person[177]|person[178]	new[176]|giv[177]|giv[178]	coref|coref	25-15[178_177]|26-3[181_178]
25-16	3244-3247	QDs	abstract[176]|person[177]|person[178]	new[176]|giv[177]|giv[178]	_	_
25-17	3248-3251	and	abstract[176]|person[178]	new[176]|giv[178]	_	_
25-18	3252-3254	FA	abstract[176]|person[178]|abstract	new[176]|giv[178]|giv	coref	30-19
25-19	3255-3257	is	_	_	_	_
25-20	3258-3261	not	_	_	_	_
25-21	3262-3269	favored	_	_	_	_
25-22	3270-3271	,	_	_	_	_
25-23	3272-3275	due	_	_	_	_
25-24	3276-3278	to	_	_	_	_
25-25	3279-3292	electrostatic	abstract[180]	new[180]	_	_
25-26	3293-3303	repulsions	abstract[180]	new[180]	_	_
25-27	3304-3305	.	_	_	_	_

#Text=Therefore , QDs coated with amino groups , which , at pH 8 , are positively charged , could improve the analytical characteristics of the sensor .
26-1	3306-3315	Therefore	_	_	_	_
26-2	3316-3317	,	_	_	_	_
26-3	3318-3321	QDs	person[181]	giv[181]	coref	27-23[0_181]
26-4	3322-3328	coated	person[181]	giv[181]	_	_
26-5	3329-3333	with	person[181]	giv[181]	_	_
26-6	3334-3339	amino	person[181]|object|person[183]	giv[181]|new|giv[183]	coref|coref	27-11[191_183]|27-26
26-7	3340-3346	groups	person[181]|person[183]	giv[181]|giv[183]	_	_
26-8	3347-3348	,	person[181]|person[183]	giv[181]|giv[183]	_	_
26-9	3349-3354	which	person[181]|person[183]	giv[181]|giv[183]	_	_
26-10	3355-3356	,	person[181]|person[183]	giv[181]|giv[183]	_	_
26-11	3357-3359	at	person[181]|person[183]	giv[181]|giv[183]	_	_
26-12	3360-3362	pH	person[181]|person[183]|abstract[184]	giv[181]|giv[183]|giv[184]	coref	28-12[203_184]
26-13	3363-3364	8	person[181]|person[183]|abstract[184]	giv[181]|giv[183]|giv[184]	_	_
26-14	3365-3366	,	person[181]|person[183]	giv[181]|giv[183]	_	_
26-15	3367-3370	are	person[181]|person[183]	giv[181]|giv[183]	_	_
26-16	3371-3381	positively	person[181]|person[183]	giv[181]|giv[183]	_	_
26-17	3382-3389	charged	person[181]|person[183]	giv[181]|giv[183]	_	_
26-18	3390-3391	,	_	_	_	_
26-19	3392-3397	could	_	_	_	_
26-20	3398-3405	improve	_	_	_	_
26-21	3406-3409	the	abstract[185]	new[185]	coref	32-6[234_185]
26-22	3410-3420	analytical	abstract[185]	new[185]	_	_
26-23	3421-3436	characteristics	abstract[185]	new[185]	_	_
26-24	3437-3439	of	abstract[185]	new[185]	_	_
26-25	3440-3443	the	abstract[185]|object[186]	new[185]|new[186]	coref	31-13[223_186]
26-26	3444-3450	sensor	abstract[185]|object[186]	new[185]|new[186]	_	_
26-27	3451-3452	.	_	_	_	_

#Text=Cysteamine ( CA ) is a bifunctional ligand , with thiol groups that bind strongly to metal ions on the surface of QDs and hydrophilic amino groups that render the QDs biocompatible and dispersible in water .
27-1	3453-3463	Cysteamine	substance	new	coref	27-6[189_0]
27-2	3464-3465	(	_	_	_	_
27-3	3466-3468	CA	abstract	new	coref	28-8
27-4	3469-3470	)	_	_	_	_
27-5	3471-3473	is	_	_	_	_
27-6	3474-3475	a	substance[189]	giv[189]	_	_
27-7	3476-3488	bifunctional	substance[189]	giv[189]	_	_
27-8	3489-3495	ligand	substance[189]	giv[189]	_	_
27-9	3496-3497	,	substance[189]	giv[189]	_	_
27-10	3498-3502	with	substance[189]	giv[189]	_	_
27-11	3503-3508	thiol	substance[189]|organization|person[191]|person[192]	giv[189]|new|giv[191]|giv[192]	coref|coref	27-11[192_191]|27-25[198_192]
27-12	3509-3515	groups	substance[189]|person[191]|person[192]	giv[189]|giv[191]|giv[192]	_	_
27-13	3516-3520	that	substance[189]|person[191]|person[192]	giv[189]|giv[191]|giv[192]	_	_
27-14	3521-3525	bind	substance[189]|person[191]|person[192]	giv[189]|giv[191]|giv[192]	_	_
27-15	3526-3534	strongly	substance[189]|person[191]|person[192]	giv[189]|giv[191]|giv[192]	_	_
27-16	3535-3537	to	substance[189]|person[191]|person[192]	giv[189]|giv[191]|giv[192]	_	_
27-17	3538-3543	metal	substance[189]|person[191]|person[192]|substance|substance[194]	giv[189]|giv[191]|giv[192]|new|new[194]	_	_
27-18	3544-3548	ions	substance[189]|person[191]|person[192]|substance[194]	giv[189]|giv[191]|giv[192]|new[194]	_	_
27-19	3549-3551	on	substance[189]|person[191]|person[192]|substance[194]	giv[189]|giv[191]|giv[192]|new[194]	_	_
27-20	3552-3555	the	substance[189]|person[191]|person[192]|substance[194]|place[195]	giv[189]|giv[191]|giv[192]|new[194]|new[195]	_	_
27-21	3556-3563	surface	substance[189]|person[191]|person[192]|substance[194]|place[195]	giv[189]|giv[191]|giv[192]|new[194]|new[195]	_	_
27-22	3564-3566	of	substance[189]|person[191]|person[192]|substance[194]|place[195]	giv[189]|giv[191]|giv[192]|new[194]|new[195]	_	_
27-23	3567-3570	QDs	substance[189]|person[191]|person[192]|substance[194]|place[195]|person	giv[189]|giv[191]|giv[192]|new[194]|new[195]|giv	coref	27-30[199_0]
27-24	3571-3574	and	substance[189]|person[192]	giv[189]|giv[192]	_	_
27-25	3575-3586	hydrophilic	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	coref	28-4[201_198]
27-26	3587-3592	amino	substance[189]|person[192]|object|person[198]	giv[189]|giv[192]|giv|giv[198]	coref	31-20
27-27	3593-3599	groups	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	_	_
27-28	3600-3604	that	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	_	_
27-29	3605-3611	render	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	_	_
27-30	3612-3615	the	substance[189]|person[192]|person[198]|person[199]	giv[189]|giv[192]|giv[198]|giv[199]	coref	29-7[209_199]
27-31	3616-3619	QDs	substance[189]|person[192]|person[198]|person[199]	giv[189]|giv[192]|giv[198]|giv[199]	_	_
27-32	3620-3633	biocompatible	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	_	_
27-33	3634-3637	and	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	_	_
27-34	3638-3649	dispersible	substance[189]|person[192]|person[198]	giv[189]|giv[192]|giv[198]	_	_
27-35	3650-3652	in	_	_	_	_
27-36	3653-3658	water	substance	new	_	_
27-37	3659-3660	.	_	_	_	_

#Text=In addition , the amino groups of CA are protonated at physiological pH and can interact with negatively charged molecules , favoring the formation of a stable assembly by electrostatic interactions .
28-1	3661-3663	In	_	_	_	_
28-2	3664-3672	addition	_	_	_	_
28-3	3673-3674	,	_	_	_	_
28-4	3675-3678	the	person[201]	giv[201]	coref	31-20[227_201]
28-5	3679-3684	amino	person[201]	giv[201]	_	_
28-6	3685-3691	groups	person[201]	giv[201]	_	_
28-7	3692-3694	of	person[201]	giv[201]	_	_
28-8	3695-3697	CA	person[201]|abstract	giv[201]|giv	coref	33-16
28-9	3698-3701	are	_	_	_	_
28-10	3702-3712	protonated	_	_	_	_
28-11	3713-3715	at	_	_	_	_
28-12	3716-3729	physiological	abstract[203]	giv[203]	coref	38-15[277_203]
28-13	3730-3732	pH	abstract[203]	giv[203]	_	_
28-14	3733-3736	and	_	_	_	_
28-15	3737-3740	can	_	_	_	_
28-16	3741-3749	interact	_	_	_	_
28-17	3750-3754	with	_	_	_	_
28-18	3755-3765	negatively	object[204]	new[204]	coref	29-15[212_204]
28-19	3766-3773	charged	object[204]	new[204]	_	_
28-20	3774-3783	molecules	object[204]	new[204]	_	_
28-21	3784-3785	,	_	_	_	_
28-22	3786-3794	favoring	_	_	_	_
28-23	3795-3798	the	event[205]	new[205]	_	_
28-24	3799-3808	formation	event[205]	new[205]	_	_
28-25	3809-3811	of	event[205]	new[205]	_	_
28-26	3812-3813	a	event[205]|event[206]	new[205]|new[206]	_	_
28-27	3814-3820	stable	event[205]|event[206]	new[205]|new[206]	_	_
28-28	3821-3829	assembly	event[205]|event[206]	new[205]|new[206]	_	_
28-29	3830-3832	by	_	_	_	_
28-30	3833-3846	electrostatic	event[207]	new[207]	coref	39-13[282_207]
28-31	3847-3859	interactions	event[207]	new[207]	_	_
28-32	3860-3861	.	_	_	_	_

#Text=There are some works based on amino-coated QDs as nanosensors for the determination of different molecules .
29-1	3862-3867	There	_	_	_	_
29-2	3868-3871	are	_	_	_	_
29-3	3872-3876	some	abstract[208]	giv[208]	_	_
29-4	3877-3882	works	abstract[208]	giv[208]	_	_
29-5	3883-3888	based	abstract[208]	giv[208]	_	_
29-6	3889-3891	on	abstract[208]	giv[208]	_	_
29-7	3892-3904	amino-coated	abstract[208]|person[209]	giv[208]|giv[209]	coref	30-13[217_209]
29-8	3905-3908	QDs	abstract[208]|person[209]	giv[208]|giv[209]	_	_
29-9	3909-3911	as	abstract[208]	giv[208]	_	_
29-10	3912-3923	nanosensors	abstract[208]|abstract[210]	giv[208]|new[210]	coref	42-11[311_210]
29-11	3924-3927	for	abstract[208]|abstract[210]	giv[208]|new[210]	_	_
29-12	3928-3931	the	abstract[208]|abstract[210]|abstract[211]	giv[208]|new[210]|new[211]	_	_
29-13	3932-3945	determination	abstract[208]|abstract[210]|abstract[211]	giv[208]|new[210]|new[211]	_	_
29-14	3946-3948	of	abstract[208]|abstract[210]|abstract[211]	giv[208]|new[210]|new[211]	_	_
29-15	3949-3958	different	abstract[208]|abstract[210]|abstract[211]|object[212]	giv[208]|new[210]|new[211]|giv[212]	_	_
29-16	3959-3968	molecules	abstract[208]|abstract[210]|abstract[211]|object[212]	giv[208]|new[210]|new[211]|giv[212]	_	_
29-17	3969-3970	.	_	_	_	_

#Text=However , to our knowledge , there are no reports based on CdTe/CA QDs for the determination of FA .
30-1	3971-3978	However	_	_	_	_
30-2	3979-3980	,	_	_	_	_
30-3	3981-3983	to	_	_	_	_
30-4	3984-3987	our	person|abstract[214]	acc|new[214]	ana	33-5
30-5	3988-3997	knowledge	abstract[214]	new[214]	_	_
30-6	3998-3999	,	_	_	_	_
30-7	4000-4005	there	_	_	_	_
30-8	4006-4009	are	_	_	_	_
30-9	4010-4012	no	abstract[215]	new[215]	_	_
30-10	4013-4020	reports	abstract[215]	new[215]	_	_
30-11	4021-4026	based	abstract[215]	new[215]	_	_
30-12	4027-4029	on	abstract[215]	new[215]	_	_
30-13	4030-4037	CdTe/CA	abstract[215]|abstract|person[217]	new[215]|new|giv[217]	coref|coref	31-17[224_217]|34-1
30-14	4038-4041	QDs	abstract[215]|person[217]	new[215]|giv[217]	_	_
30-15	4042-4045	for	abstract[215]	new[215]	_	_
30-16	4046-4049	the	abstract[215]|abstract[218]	new[215]|giv[218]	coref	33-18[242_218]
30-17	4050-4063	determination	abstract[215]|abstract[218]	new[215]|giv[218]	_	_
30-18	4064-4066	of	abstract[215]|abstract[218]	new[215]|giv[218]	_	_
30-19	4067-4069	FA	abstract[215]|abstract[218]|abstract	new[215]|giv[218]|giv	coref	31-29
30-20	4070-4071	.	_	_	_	_

#Text=Therefore , the objective of the present work is the development of a sensor based on QDs coated with amino groups and its application in the determination of FA in commercial beverages .
31-1	4072-4081	Therefore	_	_	_	_
31-2	4082-4083	,	_	_	_	_
31-3	4084-4087	the	abstract[220]	new[220]	coref	31-10[222_220]
31-4	4088-4097	objective	abstract[220]	new[220]	_	_
31-5	4098-4100	of	abstract[220]	new[220]	_	_
31-6	4101-4104	the	abstract[220]|abstract[221]	new[220]|new[221]	coref	33-2[236_221]
31-7	4105-4112	present	abstract[220]|abstract[221]	new[220]|new[221]	_	_
31-8	4113-4117	work	abstract[220]|abstract[221]	new[220]|new[221]	_	_
31-9	4118-4120	is	_	_	_	_
31-10	4121-4124	the	abstract[222]	giv[222]	ana	31-23[0_222]
31-11	4125-4136	development	abstract[222]	giv[222]	_	_
31-12	4137-4139	of	abstract[222]	giv[222]	_	_
31-13	4140-4141	a	abstract[222]|object[223]	giv[222]|giv[223]	coref	32-10[235_223]
31-14	4142-4148	sensor	abstract[222]|object[223]	giv[222]|giv[223]	_	_
31-15	4149-4154	based	abstract[222]|object[223]	giv[222]|giv[223]	_	_
31-16	4155-4157	on	abstract[222]|object[223]	giv[222]|giv[223]	_	_
31-17	4158-4161	QDs	abstract[222]|object[223]|person[224]|person[225]	giv[222]|giv[223]|giv[224]|giv[225]	coref|coref	31-17[225_224]|33-11[240_225]
31-18	4162-4168	coated	abstract[222]|object[223]|person[224]|person[225]	giv[222]|giv[223]|giv[224]|giv[225]	_	_
31-19	4169-4173	with	abstract[222]|object[223]|person[224]|person[225]	giv[222]|giv[223]|giv[224]|giv[225]	_	_
31-20	4174-4179	amino	abstract[222]|object[223]|person[224]|person[225]|object|person[227]	giv[222]|giv[223]|giv[224]|giv[225]|giv|giv[227]	_	_
31-21	4180-4186	groups	abstract[222]|object[223]|person[224]|person[225]|person[227]	giv[222]|giv[223]|giv[224]|giv[225]|giv[227]	_	_
31-22	4187-4190	and	abstract[222]|object[223]|person[225]	giv[222]|giv[223]|giv[225]	_	_
31-23	4191-4194	its	abstract[222]|object[223]|person[225]|abstract|abstract[229]	giv[222]|giv[223]|giv[225]|giv|new[229]	coref	42-14[0_229]
31-24	4195-4206	application	abstract[222]|object[223]|person[225]|abstract[229]	giv[222]|giv[223]|giv[225]|new[229]	_	_
31-25	4207-4209	in	abstract[222]|object[223]|person[225]|abstract[229]	giv[222]|giv[223]|giv[225]|new[229]	_	_
31-26	4210-4213	the	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]	giv[222]|giv[223]|giv[225]|new[229]|new[230]	_	_
31-27	4214-4227	determination	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]	giv[222]|giv[223]|giv[225]|new[229]|new[230]	_	_
31-28	4228-4230	of	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]	giv[222]|giv[223]|giv[225]|new[229]|new[230]	_	_
31-29	4231-4233	FA	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]|abstract	giv[222]|giv[223]|giv[225]|new[229]|new[230]|giv	coref	33-21
31-30	4234-4236	in	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]	giv[222]|giv[223]|giv[225]|new[229]|new[230]	_	_
31-31	4237-4247	commercial	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]|substance[232]	giv[222]|giv[223]|giv[225]|new[229]|new[230]|giv[232]	coref	41-11[0_232]
31-32	4248-4257	beverages	abstract[222]|object[223]|person[225]|abstract[229]|abstract[230]|substance[232]	giv[222]|giv[223]|giv[225]|new[229]|new[230]|giv[232]	_	_
31-33	4258-4259	.	_	_	_	_

#Text=The proposed design should improve the analytical characteristics of the sensor .
32-1	4260-4263	The	abstract[233]	new[233]	_	_
32-2	4264-4272	proposed	abstract[233]	new[233]	_	_
32-3	4273-4279	design	abstract[233]	new[233]	_	_
32-4	4280-4286	should	_	_	_	_
32-5	4287-4294	improve	_	_	_	_
32-6	4295-4298	the	abstract[234]	giv[234]	_	_
32-7	4299-4309	analytical	abstract[234]	giv[234]	_	_
32-8	4310-4325	characteristics	abstract[234]	giv[234]	_	_
32-9	4326-4328	of	abstract[234]	giv[234]	_	_
32-10	4329-4332	the	abstract[234]|object[235]	giv[234]|giv[235]	_	_
32-11	4333-4339	sensor	abstract[234]|object[235]	giv[234]|giv[235]	_	_
32-12	4340-4341	.	_	_	_	_

#Text=In this work , we present a system based on water-soluble CdTe QDs coated with CA for the determination of FA .
33-1	4342-4344	In	_	_	_	_
33-2	4345-4349	this	abstract[236]	giv[236]	_	_
33-3	4350-4354	work	abstract[236]	giv[236]	_	_
33-4	4355-4356	,	_	_	_	_
33-5	4357-4359	we	person	giv	_	_
33-6	4360-4367	present	_	_	_	_
33-7	4368-4369	a	abstract[238]	new[238]	coref	36-10[265_238]
33-8	4370-4376	system	abstract[238]	new[238]	_	_
33-9	4377-4382	based	abstract[238]	new[238]	_	_
33-10	4383-4385	on	abstract[238]	new[238]	_	_
33-11	4386-4399	water-soluble	abstract[238]|person[240]	new[238]|giv[240]	coref	35-5[256_240]
33-12	4400-4404	CdTe	abstract[238]|abstract|person[240]	new[238]|new|giv[240]	coref	35-5
33-13	4405-4408	QDs	abstract[238]|person[240]	new[238]|giv[240]	_	_
33-14	4409-4415	coated	abstract[238]|person[240]	new[238]|giv[240]	_	_
33-15	4416-4420	with	abstract[238]|person[240]	new[238]|giv[240]	_	_
33-16	4421-4423	CA	abstract[238]|person[240]|abstract	new[238]|giv[240]|giv	coref	35-9
33-17	4424-4427	for	abstract[238]|person[240]	new[238]|giv[240]	_	_
33-18	4428-4431	the	abstract[238]|person[240]|abstract[242]	new[238]|giv[240]|giv[242]	coref	36-16[267_242]
33-19	4432-4445	determination	abstract[238]|person[240]|abstract[242]	new[238]|giv[240]|giv[242]	_	_
33-20	4446-4448	of	abstract[238]|person[240]|abstract[242]	new[238]|giv[240]|giv[242]	_	_
33-21	4449-4451	FA	abstract[238]|person[240]|abstract[242]|abstract	new[238]|giv[240]|giv[242]|giv	coref	35-11
33-22	4452-4453	.	_	_	_	_

#Text=CdTe/CA was prepared and characterized by high-resolution transmission electron microscopy , FT-IR spectroscopy , the zeta potential , and UV-visible and fluorescence spectroscopy .
34-1	4454-4461	CdTe/CA	abstract	giv	coref	36-2
34-2	4462-4465	was	_	_	_	_
34-3	4466-4474	prepared	_	_	_	_
34-4	4475-4478	and	_	_	_	_
34-5	4479-4492	characterized	_	_	_	_
34-6	4493-4495	by	_	_	_	_
34-7	4496-4511	high-resolution	abstract[246]	new[246]	_	_
34-8	4512-4524	transmission	substance[245]|abstract[246]	new[245]|new[246]	_	_
34-9	4525-4533	electron	substance[245]|abstract[246]	new[245]|new[246]	_	_
34-10	4534-4544	microscopy	abstract[246]	new[246]	_	_
34-11	4545-4546	,	_	_	_	_
34-12	4547-4552	FT-IR	abstract|abstract[248]	new|giv[248]	coref	34-20[253_248]
34-13	4553-4565	spectroscopy	abstract[248]	giv[248]	_	_
34-14	4566-4567	,	_	_	_	_
34-15	4568-4571	the	abstract[250]	new[250]	coref	42-13[313_250]
34-16	4572-4576	zeta	organization|abstract[250]	new|new[250]	_	_
34-17	4577-4586	potential	abstract[250]	new[250]	_	_
34-18	4587-4588	,	_	_	_	_
34-19	4589-4592	and	_	_	_	_
34-20	4593-4603	UV-visible	abstract|abstract[253]	new|giv[253]	_	_
34-21	4604-4607	and	abstract[253]	giv[253]	_	_
34-22	4608-4620	fluorescence	abstract|abstract[253]	giv|giv[253]	coref	38-7
34-23	4621-4633	spectroscopy	abstract[253]	giv[253]	_	_
34-24	4634-4635	.	_	_	_	_

#Text=The analytical response of CdTe QDs capped with CA toward FA was studied and compared to the results obtained using other thiol-capped QDs .
35-1	4636-4639	The	abstract[254]	new[254]	_	_
35-2	4640-4650	analytical	abstract[254]	new[254]	_	_
35-3	4651-4659	response	abstract[254]	new[254]	_	_
35-4	4660-4662	of	abstract[254]	new[254]	_	_
35-5	4663-4667	CdTe	abstract[254]|abstract|person[256]	new[254]|giv|giv[256]	coref	35-21[260_256]
35-6	4668-4671	QDs	abstract[254]|person[256]	new[254]|giv[256]	_	_
35-7	4672-4678	capped	abstract[254]|person[256]	new[254]|giv[256]	_	_
35-8	4679-4683	with	abstract[254]|person[256]	new[254]|giv[256]	_	_
35-9	4684-4686	CA	abstract[254]|person[256]|abstract	new[254]|giv[256]|giv	_	_
35-10	4687-4693	toward	abstract[254]|person[256]	new[254]|giv[256]	_	_
35-11	4694-4696	FA	abstract[254]|person[256]|abstract	new[254]|giv[256]|giv	coref	36-16
35-12	4697-4700	was	_	_	_	_
35-13	4701-4708	studied	_	_	_	_
35-14	4709-4712	and	_	_	_	_
35-15	4713-4721	compared	_	_	_	_
35-16	4722-4724	to	_	_	_	_
35-17	4725-4728	the	abstract[259]	new[259]	coref	41-4[303_259]
35-18	4729-4736	results	abstract[259]	new[259]	_	_
35-19	4737-4745	obtained	abstract[259]	new[259]	_	_
35-20	4746-4751	using	_	_	_	_
35-21	4752-4757	other	person[260]	giv[260]	coref	36-2[262_260]
35-22	4758-4770	thiol-capped	person[260]	giv[260]	_	_
35-23	4771-4774	QDs	person[260]	giv[260]	_	_
35-24	4775-4776	.	_	_	_	_

#Text=As CdTe/CA QDs showed the largest quenching efficiency , this system was further studied for FA determination .
36-1	4777-4779	As	_	_	_	_
36-2	4780-4787	CdTe/CA	abstract|person[262]	giv|giv[262]	coref|coref	38-10|38-10[275_262]
36-3	4788-4791	QDs	person[262]	giv[262]	_	_
36-4	4792-4798	showed	_	_	_	_
36-5	4799-4802	the	abstract[264]	new[264]	_	_
36-6	4803-4810	largest	abstract[264]	new[264]	_	_
36-7	4811-4820	quenching	abstract|abstract[264]	new|new[264]	coref	38-6[273_0]
36-8	4821-4831	efficiency	abstract[264]	new[264]	_	_
36-9	4832-4833	,	_	_	_	_
36-10	4834-4838	this	abstract[265]	giv[265]	coref	42-1[308_265]
36-11	4839-4845	system	abstract[265]	giv[265]	_	_
36-12	4846-4849	was	_	_	_	_
36-13	4850-4857	further	_	_	_	_
36-14	4858-4865	studied	_	_	_	_
36-15	4866-4869	for	_	_	_	_
36-16	4870-4872	FA	abstract|abstract[267]	giv|giv[267]	coref	38-13[276_0]
36-17	4873-4886	determination	abstract[267]	giv[267]	_	_
36-18	4887-4888	.	_	_	_	_

#Text=The principle of this nanosensor is illustrated in Scheme 1 .
37-1	4889-4892	The	abstract[268]	new[268]	_	_
37-2	4893-4902	principle	abstract[268]	new[268]	_	_
37-3	4903-4905	of	abstract[268]	new[268]	_	_
37-4	4906-4910	this	abstract[268]|abstract[269]	new[268]|new[269]	coref	40-1[297_269]
37-5	4911-4921	nanosensor	abstract[268]|abstract[269]	new[268]|new[269]	_	_
37-6	4922-4924	is	_	_	_	_
37-7	4925-4936	illustrated	_	_	_	_
37-8	4937-4939	in	_	_	_	_
37-9	4940-4946	Scheme	abstract[270]	new[270]	_	_
37-10	4947-4948	1	abstract[270]	new[270]	_	_
37-11	4949-4950	.	_	_	_	_

#Text=The probe is based on the fluorescence quenching of CdTe/CA QDs by FA at pH 8 .
38-1	4951-4954	The	object[271]	new[271]	_	_
38-2	4955-4960	probe	object[271]	new[271]	_	_
38-3	4961-4963	is	_	_	_	_
38-4	4964-4969	based	_	_	_	_
38-5	4970-4972	on	_	_	_	_
38-6	4973-4976	the	abstract[273]	giv[273]	coref	39-5[280_273]
38-7	4977-4989	fluorescence	abstract|abstract[273]	giv|giv[273]	coref	39-5
38-8	4990-4999	quenching	abstract[273]	giv[273]	_	_
38-9	5000-5002	of	abstract[273]	giv[273]	_	_
38-10	5003-5010	CdTe/CA	abstract[273]|abstract|person[275]	giv[273]|giv|giv[275]	coref|coref	39-18|39-16[284_275]
38-11	5011-5014	QDs	abstract[273]|person[275]	giv[273]|giv[275]	_	_
38-12	5015-5017	by	_	_	_	_
38-13	5018-5020	FA	abstract[276]	giv[276]	coref	39-29[289_276]
38-14	5021-5023	at	abstract[276]	giv[276]	_	_
38-15	5024-5026	pH	abstract[276]|abstract[277]	giv[276]|giv[277]	_	_
38-16	5027-5028	8	abstract[276]|abstract[277]	giv[276]|giv[277]	_	_
38-17	5029-5030	.	_	_	_	_

#Text=A probable mechanism of fluorescence quenching based on the coordinated behavior of electrostatic interactions between positively charged CdTe/CA QDs ( ethylamine groups , pKa = 10.52 ) and negatively charged FA ( carboxylic groups , pKa = 3.46 and pKa = 4.83 ) and the electronic transfer of QDs to FA is proposed .
39-1	5031-5032	A	abstract[278]	new[278]	_	_
39-2	5033-5041	probable	abstract[278]	new[278]	_	_
39-3	5042-5051	mechanism	abstract[278]	new[278]	_	_
39-4	5052-5054	of	abstract[278]	new[278]	_	_
39-5	5055-5067	fluorescence	abstract[278]|abstract|abstract[280]	new[278]|giv|giv[280]	_	_
39-6	5068-5077	quenching	abstract[278]|abstract[280]	new[278]|giv[280]	_	_
39-7	5078-5083	based	abstract[278]	new[278]	_	_
39-8	5084-5086	on	abstract[278]	new[278]	_	_
39-9	5087-5090	the	abstract[278]|abstract[281]	new[278]|new[281]	_	_
39-10	5091-5102	coordinated	abstract[278]|abstract[281]	new[278]|new[281]	_	_
39-11	5103-5111	behavior	abstract[278]|abstract[281]	new[278]|new[281]	_	_
39-12	5112-5114	of	abstract[278]|abstract[281]	new[278]|new[281]	_	_
39-13	5115-5128	electrostatic	abstract[278]|abstract[281]|event[282]	new[278]|new[281]|giv[282]	_	_
39-14	5129-5141	interactions	abstract[278]|abstract[281]|event[282]	new[278]|new[281]|giv[282]	_	_
39-15	5142-5149	between	abstract[278]|abstract[281]|event[282]	new[278]|new[281]|giv[282]	_	_
39-16	5150-5160	positively	abstract[278]|abstract[281]|event[282]|person[284]	new[278]|new[281]|giv[282]|giv[284]	appos	39-21[286_284]
39-17	5161-5168	charged	abstract[278]|abstract[281]|event[282]|person[284]	new[278]|new[281]|giv[282]|giv[284]	_	_
39-18	5169-5176	CdTe/CA	abstract[278]|abstract[281]|event[282]|abstract|person[284]	new[278]|new[281]|giv[282]|giv|giv[284]	_	_
39-19	5177-5180	QDs	abstract[278]|abstract[281]|event[282]|person[284]	new[278]|new[281]|giv[282]|giv[284]	_	_
39-20	5181-5182	(	_	_	_	_
39-21	5183-5193	ethylamine	abstract|person[286]	new|giv[286]	coref	39-49[0_286]
39-22	5194-5200	groups	person[286]	giv[286]	_	_
39-23	5201-5202	,	_	_	_	_
39-24	5203-5206	pKa	abstract	new	_	_
39-25	5207-5208	=	_	_	_	_
39-26	5209-5214	10.52	abstract	new	_	_
39-27	5215-5216	)	_	_	_	_
39-28	5217-5220	and	_	_	_	_
39-29	5221-5231	negatively	abstract[289]	giv[289]	coref	39-51[0_289]
39-30	5232-5239	charged	abstract[289]	giv[289]	_	_
39-31	5240-5242	FA	abstract[289]	giv[289]	_	_
39-32	5243-5244	(	abstract[289]	giv[289]	_	_
39-33	5245-5255	carboxylic	abstract[289]	giv[289]	_	_
39-34	5256-5262	groups	abstract[289]	giv[289]	_	_
39-35	5263-5264	,	abstract[289]	giv[289]	_	_
39-36	5265-5269	pKa	abstract[289]|abstract	giv[289]|new	_	_
39-37	5270-5271	=	abstract[289]	giv[289]	_	_
39-38	5272-5276	3.46	abstract[289]|abstract	giv[289]|new	_	_
39-39	5277-5280	and	abstract[289]	giv[289]	_	_
39-40	5281-5285	pKa	abstract[289]|abstract	giv[289]|new	_	_
39-41	5286-5287	=	abstract[289]	giv[289]	_	_
39-42	5288-5292	4.83	abstract[289]|abstract	giv[289]|new	_	_
39-43	5293-5294	)	abstract[289]	giv[289]	_	_
39-44	5295-5298	and	_	_	_	_
39-45	5299-5302	the	event[294]	new[294]	_	_
39-46	5303-5313	electronic	event[294]	new[294]	_	_
39-47	5314-5322	transfer	event[294]	new[294]	_	_
39-48	5323-5325	of	event[294]	new[294]	_	_
39-49	5326-5329	QDs	event[294]|person	new[294]|giv	_	_
39-50	5330-5332	to	event[294]	new[294]	_	_
39-51	5333-5335	FA	event[294]|abstract	new[294]|giv	coref	41-8
39-52	5336-5338	is	_	_	_	_
39-53	5339-5347	proposed	_	_	_	_
39-54	5348-5349	.	_	_	_	_

#Text=The nanosensor is rapid , easy to obtain , and shows a low detection limit , high selectivity , and low cost .
40-1	5350-5353	The	abstract[297]	giv[297]	_	_
40-2	5354-5364	nanosensor	abstract[297]	giv[297]	_	_
40-3	5365-5367	is	_	_	_	_
40-4	5368-5373	rapid	_	_	_	_
40-5	5374-5375	,	_	_	_	_
40-6	5376-5380	easy	_	_	_	_
40-7	5381-5383	to	_	_	_	_
40-8	5384-5390	obtain	_	_	_	_
40-9	5391-5392	,	_	_	_	_
40-10	5393-5396	and	_	_	_	_
40-11	5397-5402	shows	_	_	_	_
40-12	5403-5404	a	abstract[299]	new[299]	_	_
40-13	5405-5408	low	abstract[299]	new[299]	_	_
40-14	5409-5418	detection	abstract|abstract[299]	giv|new[299]	_	_
40-15	5419-5424	limit	abstract[299]	new[299]	_	_
40-16	5425-5426	,	_	_	_	_
40-17	5427-5431	high	abstract[300]	new[300]	_	_
40-18	5432-5443	selectivity	abstract[300]	new[300]	_	_
40-19	5444-5445	,	_	_	_	_
40-20	5446-5449	and	_	_	_	_
40-21	5450-5453	low	abstract[301]	new[301]	_	_
40-22	5454-5458	cost	abstract[301]	new[301]	_	_
40-23	5459-5460	.	_	_	_	_

#Text=The method showed excellent results in detecting FA contents in beverages ( recoveries from 98.3 to 103.9 % ) .
41-1	5461-5464	The	abstract[302]	new[302]	_	_
41-2	5465-5471	method	abstract[302]	new[302]	_	_
41-3	5472-5478	showed	_	_	_	_
41-4	5479-5488	excellent	abstract[303]	giv[303]	_	_
41-5	5489-5496	results	abstract[303]	giv[303]	_	_
41-6	5497-5499	in	abstract[303]	giv[303]	_	_
41-7	5500-5509	detecting	abstract[303]	giv[303]	_	_
41-8	5510-5512	FA	abstract[303]|abstract|substance[305]	giv[303]|giv|new[305]	_	_
41-9	5513-5521	contents	abstract[303]|substance[305]	giv[303]|new[305]	_	_
41-10	5522-5524	in	abstract[303]	giv[303]	_	_
41-11	5525-5534	beverages	abstract[303]|substance	giv[303]|giv	_	_
41-12	5535-5536	(	_	_	_	_
41-13	5537-5547	recoveries	_	_	_	_
41-14	5548-5552	from	_	_	_	_
41-15	5553-5557	98.3	abstract[307]	new[307]	_	_
41-16	5558-5560	to	abstract[307]	new[307]	_	_
41-17	5561-5566	103.9	abstract[307]	new[307]	_	_
41-18	5567-5568	%	abstract[307]	new[307]	_	_
41-19	5569-5570	)	_	_	_	_
41-20	5571-5572	.	_	_	_	_

#Text=The system provides a new approach for the construction of nanosensors with high application potential in different areas .
42-1	5573-5576	The	abstract[308]	giv[308]	_	_
42-2	5577-5583	system	abstract[308]	giv[308]	_	_
42-3	5584-5592	provides	_	_	_	_
42-4	5593-5594	a	abstract[309]	new[309]	_	_
42-5	5595-5598	new	abstract[309]	new[309]	_	_
42-6	5599-5607	approach	abstract[309]	new[309]	_	_
42-7	5608-5611	for	abstract[309]	new[309]	_	_
42-8	5612-5615	the	abstract[309]|event[310]	new[309]|new[310]	_	_
42-9	5616-5628	construction	abstract[309]|event[310]	new[309]|new[310]	_	_
42-10	5629-5631	of	abstract[309]|event[310]	new[309]|new[310]	_	_
42-11	5632-5643	nanosensors	abstract[309]|event[310]|abstract[311]	new[309]|new[310]|giv[311]	_	_
42-12	5644-5648	with	abstract[309]|event[310]|abstract[311]	new[309]|new[310]|giv[311]	_	_
42-13	5649-5653	high	abstract[309]|event[310]|abstract[311]|abstract[313]	new[309]|new[310]|giv[311]|giv[313]	_	_
42-14	5654-5665	application	abstract[309]|event[310]|abstract[311]|abstract|abstract[313]	new[309]|new[310]|giv[311]|giv|giv[313]	_	_
42-15	5666-5675	potential	abstract[309]|event[310]|abstract[311]|abstract[313]	new[309]|new[310]|giv[311]|giv[313]	_	_
42-16	5676-5678	in	abstract[309]|event[310]|abstract[311]|abstract[313]	new[309]|new[310]|giv[311]|giv[313]	_	_
42-17	5679-5688	different	abstract[309]|event[310]|abstract[311]|abstract[313]|abstract[314]	new[309]|new[310]|giv[311]|giv[313]|new[314]	_	_
42-18	5689-5694	areas	abstract[309]|event[310]|abstract[311]|abstract[313]|abstract[314]	new[309]|new[310]|giv[311]|giv[313]|new[314]	_	_
42-19	5695-5696	.	_	_	_	_
